Ledger.Open graph →
SEC Form D · filed June 23, 2020

Angion Biomedica Corp

Offering
$40.0M
Sold
$6.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Itzhak D. Goldberg · Uniondale, NYExec · DirectorGil R. Omenn · San Francisco, CADirectorStephen King · Los Gatos, CAExec · DirectorJason Seedig · Highlands Ranch, COExec · DirectorJay R. Venkatesan · San Francisco, CAExec · DirectorAllen R. Nissenson · San Francisco, CADirectorJay R. Venkatesan · San Francisco, CAExec · DirectorAllen R. Nissenson · San Francisco, CADirectorVictor R. Ganzi · San Francisco, CADirectorKaren R. Wilson · San Francisco, CADirectorVictor R. Ganzi · San Francisco, CADirectorKaren R. Wilson · San Francisco, CADirectorGil R. Omenn · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗